Cargando…

Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease

Mutations in the EPM2A and EPM2B genes, encoding laforin and malin proteins respectively, are responsible for Lafora disease, a fatal form of progressive myoclonus epilepsy with autosomal recessive inheritance. Neuroimaging studies of patients with Lafora disease have shown different degrees of brai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgos, Daniel F., Cussó, Lorena, Sánchez-Elexpuru, Gentzane, Calle, Daniel, Perpinyà, Max Bautista, Desco, Manuel, Serratosa, José M., Sánchez, Marina P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589150/ https://www.ncbi.nlm.nih.gov/pubmed/33092303 http://dx.doi.org/10.3390/ijms21207771

Ejemplares similares

Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models
por: Sánchez, Marina P., et al.
Publicado: (2018)

Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole
por: García-Cabrero, Ana M., et al.
Publicado: (2014)

Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease
por: Sanz, Pascual, et al.
Publicado: (2021)

Effect of illumination level [18F]FDG-PET brain uptake in free moving mice
por: de Francisco, Alexandra, et al.
Publicado: (2021)

Suppression of (18)F-FDG signal in the bladder on small animal PET-CT
por: Cussó, Lorena, et al.
Publicado: (2018)

Toward the use of novel alternative methods in epilepsy modeling and drug discovery
por: Miguel Sanz, Claudia, et al.
Publicado: (2023)

An empirical pipeline for personalized diagnosis of Lafora disease mutations
por: Brewer, M. Kathryn, et al.
Publicado: (2021)

Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020)

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

Unusual Course of Lafora Disease
por: Zutt, Rodi, et al.
Publicado: (2016)

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
por: Nitschke, Felix, et al.
Publicado: (2017)

Ocular phenotype and electroretinogram abnormalities in Lafora disease and correlation with disease stage
por: Orsini, Alessandro, et al.
Publicado: (2022)

A PTG Variant Contributes to a Milder Phenotype in Lafora Disease
por: Guerrero, Rosa, et al.
Publicado: (2011)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

Canine Lafora Disease: An Unstable Repeat Expansion Disorder
por: von Klopmann, Thilo, et al.
Publicado: (2021)

An inducible expression system for the manipulation of autophagic flux in vivo
por: Schlotawa, Lars, et al.
Publicado: (2022)

Comparison of Methods to Reduce Myocardial 18F-FDG Uptake in Mice: Calcium Channel Blockers versus High-Fat Diets
por: Cussó, Lorena, et al.
Publicado: (2014)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

Lafora Disease Masquerading as Hepatic Dysfunction
por: Inayat, Faisal, et al.
Publicado: (2018)

Lafora disease in miniature Wirehaired Dachshunds
por: Swain, Lindsay, et al.
Publicado: (2017)

Retinal alterations in patients with Lafora disease
por: Heitkotter, Heather, et al.
Publicado: (2021)

Lafora disease: a case report
por: Zeka, Naim, et al.
Publicado: (2022)

Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model
por: Mollá, Belén, et al.
Publicado: (2022)

In-line high resolution PET and 3T MRI hybrid device for preclinical multimodal imaging
por: Vaquero, Juan J, et al.
Publicado: (2014)

Vagus nerve stimulation in Lafora body disease()
por: Hajnsek, Sanja, et al.
Publicado: (2013)

Lafora Disease: A Ubiquitination-Related Pathology
por: García-Gimeno, Maria Adelaida, et al.
Publicado: (2018)

Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019)

Lafora Disease: Report of a Rare Entity
por: Al Mufargi, Younis, et al.
Publicado: (2020)

Trehalose Treatment in Zebrafish Model of Lafora Disease
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model
por: Moreno-Estellés, Mireia, et al.
Publicado: (2023)

Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease
por: Valles-Ortega, Jordi, et al.
Publicado: (2011)

Genetics of Lafora progressive myoclonic epilepsy: current perspectives
por: Kecmanović, Miljana, et al.
Publicado: (2016)

Extraneurological sparing in long‐lived typical Lafora disease
por: Goldsmith, Danielle, et al.
Publicado: (2018)

Genotypes and phenotypes of patients with Lafora disease living in Germany
por: Brenner, David, et al.
Publicado: (2019)

Glial Contributions to Lafora Disease: A Systematic Review
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Retinal Phenotyping of a Murine Model of Lafora Disease
por: Vincent, Ajoy, et al.
Publicado: (2023)

Unexpected Phenotype Reversion and Survival in a Zebrafish Model of Multiple Sulfatase Deficiency
por: Fleming, Angeleen, et al.
Publicado: (2022)

Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease
por: Ortolano, Saida, et al.
Publicado: (2014)

Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel
por: Dirani, Maya, et al.
Publicado: (2014)

Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6pe9mq4qmqoi99kbcc0hsce5sh